Effects of Capsinoids on Daily Physical Activity, Body Composition and Cold Hypersensitivity in Middle-Aged and Older Adults: A Randomized Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
14 Jan 2020
Historique:
received: 03 12 2019
revised: 05 01 2020
accepted: 09 01 2020
entrez: 18 1 2020
pubmed: 18 1 2020
medline: 12 11 2020
Statut: epublish

Résumé

Sedentary/inactive lifestyle leads middle-aged and older adults to metabolic syndrome and frailty. Capsinoids from nonpungent chili pepper cultivar have been reported to reduce body fat mass, promote metabolism, and improve unidentified complaints of chills. Additionally, they have an anti-inflammation effect; therefore, we hypothesized that continuous oral ingestion of capsinoids alleviates age-related inflammation in the brain and improves the physical activity (PA) in middle-aged and older adults. In our double-blind human study, 69 participants (17 male, 52 female; mean age: 74.1 ± 7.7 years; range: 52-87 years) were administered either 9 mg of capsinoids which were extracted from pepper fruit variety CH-19 Sweet (

Identifiants

pubmed: 31947529
pii: nu12010212
doi: 10.3390/nu12010212
pmc: PMC7019503
pii:
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Plant Extracts 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Références

Eur J Immunol. 2002 Jun;32(6):1753-63
pubmed: 12115659
Int J Nanomedicine. 2014 Feb 11;9:823-39
pubmed: 24596461
Eur J Appl Physiol. 2018 Oct;118(10):2133-2146
pubmed: 30019086
Food Nutr Res. 2008;52:
pubmed: 19158939
PLoS One. 2017 Jun 9;12(6):e0178654
pubmed: 28598993
Free Radic Biol Med. 2010 Dec 1;49(11):1603-16
pubmed: 20840865
Biosci Biotechnol Biochem. 2007 Mar;71(3):671-6
pubmed: 17341828
FASEB J. 2017 Jan;31(1):5-10
pubmed: 28049155
J Appl Physiol (1985). 2003 Dec;95(6):2408-15
pubmed: 12959953
CMAJ. 2006 Mar 14;174(6):801-9
pubmed: 16534088
PLoS One. 2014 Mar 12;9(3):e90950
pubmed: 24621600
Am J Epidemiol. 2010 Nov 15;172(10):1155-65
pubmed: 20843864
J Biomed Opt. 2016 Sep;21(9):091305
pubmed: 27135066
Age (Dordr). 2012 Feb;34(1):203-14
pubmed: 21424789
Diabetologia. 2012 Nov;55(11):2895-905
pubmed: 22890825
Eur J Appl Physiol. 2009 Jan;105(1):141-52
pubmed: 18853176
Neurology. 2011 Sep 20;77(12):1126-34
pubmed: 21931106
Am J Physiol Endocrinol Metab. 2014 May 15;306(10):E1110-9
pubmed: 24644244
Int J Mol Sci. 2016 Dec 02;17(12):
pubmed: 27918465
Curr Opin Lipidol. 2013 Feb;24(1):71-7
pubmed: 23298960
Am J Clin Nutr. 2010 Oct;92(4):826-34
pubmed: 20810973
Neurology. 2018 Oct 16;91(16):e1461-e1467
pubmed: 30232251
J Integr Med. 2018 Jan;16(1):34-38
pubmed: 29397090
Med Sci Sports Exerc. 2010 May;42(5):879-85
pubmed: 19996993
Am J Clin Nutr. 2009 Jan;89(1):45-50
pubmed: 19056576
Biosci Biotechnol Biochem. 2006 Apr;70(4):774-81
pubmed: 16636441
Curr Opin Cardiol. 2017 Sep;32(5):541-556
pubmed: 28708630
J Phys Act Health. 2014 Feb;11(2):266-71
pubmed: 23359136
Hypertension. 2011 Jul;58(1):22-8
pubmed: 21555680
Eur J Clin Nutr. 2007 Nov;61(11):1256-61
pubmed: 17299487
Eur J Pharmacol. 2011 Jan 10;650(1):1-7
pubmed: 20946891
Ageing Res Rev. 2011 Jan;10(1):104-14
pubmed: 20850567
Int J Geriatr Psychiatry. 2011 Nov;26(11):1109-18
pubmed: 21370276
J Clin Invest. 2013 Aug;123(8):3404-8
pubmed: 23867622
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Am J Physiol Endocrinol Metab. 2017 Nov 1;313(5):E586-E597
pubmed: 28811294
Am J Physiol Regul Integr Comp Physiol. 2000 Jul;279(1):R349-54
pubmed: 10896899
Ann N Y Acad Sci. 2000 Jun;908:244-54
pubmed: 10911963
JAMA. 2003 Apr 9;289(14):1785-91
pubmed: 12684356
PLoS One. 2015 Jun 01;10(6):e0128016
pubmed: 26030806
Curr Opin Psychiatry. 2005 Mar;18(2):189-93
pubmed: 16639173
Eur J Epidemiol. 2016 Mar;31(3):267-74
pubmed: 26857126
Clin Chem. 1977 Jul;23(7):1226-9
pubmed: 872368

Auteurs

Keiichi Yokoyama (K)

Institute for Active Health, Institutes of Interdisciplinary Research, Kyoto University of Advanced Science, 1-1 Nanjo Otani, Sogabe-cho, Kameoka-city, Kyoto 621-8555, Japan.
Nonprofit Organization Genki-up AGE Project, Kameoka-city, Kyoto 621-8555, Japan.

Yosuke Yamada (Y)

Institute for Active Health, Institutes of Interdisciplinary Research, Kyoto University of Advanced Science, 1-1 Nanjo Otani, Sogabe-cho, Kameoka-city, Kyoto 621-8555, Japan.
Nonprofit Organization Genki-up AGE Project, Kameoka-city, Kyoto 621-8555, Japan.

Yasunori Akamatsu (Y)

Center for Faculty Development, Kyoto University of Advanced Science, 1-1 Nanjo Otani, Sogabe-cho, Kameoka-city, Kyoto 621-8555, Japan.
Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto City, Kyoto 612-8555, Japan.

Yasuko Yoshinaka (Y)

Nonprofit Organization Genki-up AGE Project, Kameoka-city, Kyoto 621-8555, Japan.
Center for Faculty Development, Kyoto University of Advanced Science, 1-1 Nanjo Otani, Sogabe-cho, Kameoka-city, Kyoto 621-8555, Japan.

Akiko Yamamoto (A)

Ajinomoto Co., Inc., Institute of Food Sciences & Technologies, 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki City, Kanagawa 210-8681, Japan.

Tomonori Koizumi (T)

Ajinomoto Co., Inc., Institute of Food Sciences & Technologies, 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki City, Kanagawa 210-8681, Japan.

Kana Ohyama (K)

Ajinomoto Co., Inc., Task Force for Nutrition Strategy, 15-1, Kyobashi 1-chome, Chuo-ku, Tokyo 104-8315, Japan.

Katsuya Suzuki (K)

Ajinomoto Co., Inc., Institute of Food Sciences & Technologies, 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki City, Kanagawa 210-8681, Japan.

Masaki Hashimoto (M)

Ajinomoto Co., Inc., Direct Marketing Department, 15-1, Kyobashi 1-chome, Chuo-ku, Tokyo 104-8315, Japan.

Hitoshi Sato (H)

Ajinomoto Co., Inc., Quality Assurance Department, 15-1, Kyobashi 1-chome, Chuo-ku, Tokyo 104-8315, Japan.

Misaka Kimura (M)

Institute for Active Health, Institutes of Interdisciplinary Research, Kyoto University of Advanced Science, 1-1 Nanjo Otani, Sogabe-cho, Kameoka-city, Kyoto 621-8555, Japan.
Nonprofit Organization Genki-up AGE Project, Kameoka-city, Kyoto 621-8555, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH